Clinical Trial Update: Altretamine and Etoposide in Treating Patients With HIV-Related Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating altretamine and etoposide in patients with HIV-related cancer (lymphoma and sarcoma) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Sarcoma

Drugs mentioned

• Hexalen (altretamine)
• Toposar (Etoposide)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Lymphoma, Sarcoma | Phase 1 | Status: COMPLETED